Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma
- 1 January 2007
- journal article
- letter
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 48 (9) , 1849-1851
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemiaBlood, 2007
- A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt®) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III studyJournal of Neuro-Oncology, 2006
- Phase I Trial of Intrathecal Liposomal Cytarabine in Children With Neoplastic MeningitisJournal of Clinical Oncology, 2004
- Outcome with the hyper-CVAD regimens in lymphoblastic lymphomaBlood, 2004
- Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous MeningitisJournal of Clinical Oncology, 1999